Clinical Trial Update: Reduced Intensity Preparative Regimen Followed by Stem Cell Transplant (FAB) [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on a reduced-intensity preparative regimen followed by stem cell transplantation (FAB) in several hematologic malignancies; the Phase 1/2 …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Chronic Myeloid Leukemia
• Lymphoproliferative Disorders
• Multiple Myeloma
• Myelodysplastic Syndromes
• Myeloproliferative Neoplasms
• Plasma Cell Dyscrasia

Snippet

Sponsor: Baylor College of Medicine | Conditions: Myelodysplastic and Myeloproliferative Disorders, Acute Myelogenous Leukemia | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2012-08-09